Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome

BACKGROUND: The prevalence of nonalcoholic fatty liver disease (NAFLD) in the non-obese population has increased and NAFLD is not always recognized in individuals with metabolic syndrome (MS). The risk of cirrhosis is higher in patients having NAFLD with elevated alanine aminotransferase (ALT) level...

Descripción completa

Detalles Bibliográficos
Autores principales: Sogabe, Masahiro, Okahisa, Toshiya, Kurihara, Takeshi, Takehara, Masanori, Kagemoto, Kaizo, Okazaki, Jun, Kida, Yoshifumi, Hirao, Akihiro, Tanaka, Hironori, Tomonari, Tetsu, Taniguchi, Tatsuya, Okamoto, Koichi, Nakasono, Masahiko, Takayama, Tetsuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458345/
https://www.ncbi.nlm.nih.gov/pubmed/32866186
http://dx.doi.org/10.1371/journal.pone.0238388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458345/
https://www.ncbi.nlm.nih.gov/pubmed/32866186
http://dx.doi.org/10.1371/journal.pone.0238388

Ejemplares similares